Similar articles

• Dopamine infusion enhances the adrenocorticotropic hormone and cortisol response to metoclopramide in hyperprolactinemic patients but not in normal subjects.

  Moro M, Maraschini C, Cavagnini F. Moro M, et al. Gynecol Endocrinol. 1997 Jun;11(3):155-62. doi: 10.3109/09513599709152529. Gynecol Endocrinol. 1997. PMID: 9209895 Clinical Trial.
• Hormonal response during antigenic challenge in normal subjects.

  Catania A, Airaghi L, Manfredi G, Zanussi C. Catania A, et al. Int J Neurosci. 1990 Apr;51(3-4):295-6. doi: 10.3109/00207459008999724. Int J Neurosci. 1990. PMID: 2177738 No abstract available.
• Diagnostic value of thyrotrophin-releasing hormone in pituitary and hypothalamic diseases. Assessment of thyrotrophin and prolactin secretion in 100 patients.

  Snyder PJ, Jacobs LS, Rabello MM, Sterling FH, Shore RN, Utiger RD, Daughaday WH. Snyder PJ, et al. Ann Intern Med. 1974 Dec;81(6):751-7. doi: 10.7326/0003-4819-81-6-751. Ann Intern Med. 1974. PMID: 4372919 No abstract available.
• Growth hormone secretagogues as corticotrophin-releasing factors.

  Ghigo E, Arvat E, Camanni F. Ghigo E, et al. Growth Horm IGF Res. 1998 Apr;8 Suppl B:145-8. doi: 10.1016/s1096-6374(98)80040-3. Growth Horm IGF Res. 1998. PMID: 10990151 Review. No abstract available.
• Prolactin secretion as an index of brain dopaminergic function.

  Thorner MO, Login IS. Thorner MO, et al. Adv Biochem Psychopharmacol. 1981;28:503-20. Adv Biochem Psychopharmacol. 1981. PMID: 6452035 Review. No abstract available.